Skip to main content
David Ilson, MD, Oncology, New York, NY

DavidHIlsonMD

Oncology New York, NY

Hematologic Oncology

Professor of Medicine, Cornell Univ-Weill Medical College

Overview of Dr. Ilson

Dr. David Ilson is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Monmouth. He received his medical degree from New York University Grossman School of Medicine and has been in practice 31 years. Dr. Ilson accepts several types of health insurance, listed below. He is one of 493 doctors at Memorial Sloan Kettering Cancer Center and one of 14 doctors at Memorial Sloan Kettering Monmouth who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineInternship, Internal Medicine, 1986 - 1987
  • New York University School of Medicine
    New York University School of MedicineClass of 1986

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 1987 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2007-2014
  • America's Top Doctors for Cancer Castle Connolly, 2007-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ESMO 2022: New Research in Treating Gastrointestinal and Genitourinary Cancers
    ESMO 2022: New Research in Treating Gastrointestinal and Genitourinary CancersNovember 10th, 2022
  • Immune Checkpoint, VEGFR Inhibitor Combo Effective in Advanced Esophageal Cancer
    Immune Checkpoint, VEGFR Inhibitor Combo Effective in Advanced Esophageal CancerJanuary 10th, 2022
  • Breakthrough Research from Baylor Scott & White Health Transforms the Future of Cancer Care
    Breakthrough Research from Baylor Scott & White Health Transforms the Future of Cancer CareJuly 29th, 2021
  • Join now to see all

Insurance Accepted

  • BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment